Home > Blog > Diane Fennell > Additional Lots of Losartan Recalled
Additional Lots of Losartan Recalled

Additional Lots of Losartan Recalled

By Diane Fennell
Print Text Size: A A A

Manufacturer Torrent Pharmaceuticals Limited is recalling 36 additional lots of the blood pressure drug losartan potassium and 68 additional lots of losartan-hydrochlorothiazide combination tablets due to detection of trace amounts of the carcinogen N-Methylnitrosobutyric acid (NMBA) above acceptable daily levels set by the U.S. Food and Drug Administration (FDA).

Advertisement

Information about the nationwide recall, including details on products and lots, is available on the FDA website.

To date, there have not been reports of adverse events related to this recall. To learn more about the recall, contact Torrent Pharmaceuticals at (800) 912-9561 or [email protected].

Learn more about the health and medical experts who who provide you with the cutting-edge resources, tools, news, and more on Diabetes Self-Management.
About Our Experts >>

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.

All comments are moderated and there may be a delay in the publication of your comment. Please be on-topic and appropriate. Do not disclose personal information. Be respectful of other posters. Only post information that is correct and true to your knowledge. When referencing information that is not based on personal experience, please provide links to your sources. All commenters are considered to be nonmedical professionals unless explicitly stated otherwise. Promotion of your own or someone else's business or competing site is not allowed: Sharing links to sites that are relevant to the topic at hand is permitted, but advertising is not. Once submitted, comments cannot be modified or deleted by their authors. Comments that don't follow the guidelines above may be deleted without warning. Such actions are at the sole discretion of DiabetesSelfManagement.com. Comments are moderated Monday through Friday by the editors of DiabetesSelfManagement.com. The moderators are employees of Madavor Media, LLC and do not report any conflicts of interest. A privacy policy setting forth our policies regarding the collection, use, and disclosure of certain information relating to you and your use of this Web site can be found here. For more information, please read our Terms and Conditions